Advances in Atherosclerosis Theranostics Harnessing Iron Oxide-Based Nanoparticles

Area of Science:

• Biomedical Engineering
• Nanotechnology
• Cardiovascular Medicine

Background:

• Atherosclerosis is a chronic inflammatory disease with challenges in early detection, plaque stability assessment, and effective treatment.
• Current management limitations necessitate innovative approaches for improved cardiovascular health.
• Nanotheranostics, combining diagnostics and therapeutics, present a novel strategy.

Purpose of the Study:

• To review the current state and future prospects of iron oxide nanoparticle-based nanotheranostics for atherosclerosis.
• To discuss the role of iron oxide nanoparticles in atherosclerosis development, targeting, diagnosis, and therapy.
• To explore various theranostic nanomedicine approaches using iron oxide nanoparticles.

Main Methods:

• Literature review focusing on iron oxide nanoparticles in atherosclerosis nanotheranostics.
• Analysis of atherosclerosis pathogenesis and relevant targeting strategies.
• Overview of diagnostic and therapeutic applications, including chemical, physical, and biological therapies.

Main Results:

• Iron oxide nanoparticles show potential for magnetic resonance imaging and targeted delivery in atherosclerosis.
• Nanotheranostic strategies encompass chemical, physical, and biological therapeutic interventions.
• These nanoparticles offer a dual role in diagnosis and therapy for atherosclerosis.

Conclusions:

• Iron oxide nanoparticle-based nanotheranostics hold significant promise for advancing atherosclerosis management.
• Further research and clinical translation are needed to overcome current challenges.
• These nanoparticles represent versatile tools for future anti-atherosclerosis interventions.